SMS Pharmaceuticals informs about updates

22 Mar 2025 Evaluate

SMS Pharmaceuticals has informed, the United States Food and Drug Administration (USFDA) has conducted an inspection of the Company’s Active Pharmaceutical Ingredient (API) manufacturing facility located at Bachupally, Hyderabad, Telangana, it has the enclosed Company statement titled ‘Successful completion of USFDA inspection at Hyderabad facility’. The above information will also be made available on the website of the Company at www.smspharma.com.

The above information is a part of company’s filings submitted to BSE.


SMS Pharmaceuticals Share Price

321.25 11.85 (3.83%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×